Next Post

Reaction Biology Announces Appointment of Richard S. Kollender to Chief Financial Officer and Chief Business Officer | News

MALVERN, Pa., April 4, 2022 /PRNewswire/ — Reaction Biology (“Reaction” or the “Company”), an industry-leading provider of drug discovery services, today announced the appointment of Richard S. Kollender to the positions of Chief Financial Officer (CFO), Chief Business Officer (CBO) and member of the Executive Committee, effective immediately, to further […]